Amongst patients taking biologic therapies for axial spondyloarthritis, which factors are associated with work non-participation?
Tom Nadin(Sheffield Teaching Hospitals NHS Foundation Trust), Christopher J Edwards(University Hospital Southampton NHS Foundation Trust), Karen Walker‐Bone(Monash University), Christopher Holroyd(Southampton General Hospital), Stefania D’Angelo(University Hospital Southampton NHS Foundation Trust), Dinny Wallis(University Hospital Southampton NHS Foundation Trust)
Cited by 7
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
2022 update
|Radboud Repository (Radboud University)|2010|1.6k
EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis
|Annals of the Rheumatic Diseases|2013|668
Vitamin D supplementation in pregnancy: a systematic review
|Health Technology Assessment|2014|353